All Updates

All Updates

icon
Filter
Partnerships
Biognosys collaborates with Alamar Biosciences to expand services and to research on biofluid-based proteomics
Precision Medicine
Apr 4, 2024
This week:
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Funding
OceanWell raises USD 11 million in Series A funding to build water farms
Conservation Tech
Yesterday
Product updates
H launches Runner H, an AI agent for business automation
Foundation Models
Yesterday
Partnerships
Capgemini partners with Mistral AI and Microsoft to expand GenAI solutions globally
Foundation Models
Yesterday
Funding
Product updates
Converge Bio launches biotech LLM platform with USD 5.5 million seed funding
Foundation Models
Yesterday
Partnerships
Snowflake partners with Anthropic to integrate Claude AI models into Cortex AI platform
Foundation Models
Yesterday
Product updates
DeepSeek releases AI reasoning model DeepSeek-R1
Foundation Models
Yesterday
Industry news
Partnerships
ICEYE partners with Lockheed Martin and Finnish firms to develop defense space technologies
Next-gen Satellites
Yesterday
Partnerships
Dematic installs AutoStore system at South West Healthcare logistics hub
Logistics Tech
Yesterday
Precision Medicine

Precision Medicine

Apr 4, 2024

Biognosys collaborates with Alamar Biosciences to expand services and to research on biofluid-based proteomics

Partnerships

  • Biognosys has entered a partnership with Alamar Biosciences to expand services and to research biofluid-based proteomics. The collaboration brings together Biognosys' DIA-MS (data independent acquisition mass spectrometry) expertise and Alamar's immunoassays, such as NULISA assays for low-abundance proteins such as cytokines, chemokines, and important disease protein biomarkers from plasma. A successful pilot study has already been conducted on Non-Small Cell Lung Cancer (NSCLC).

  • Biognosys AG is a Switzerland-based biotech company specializing in proteomics. The company uses patented high-resolution mass spectrometry technology for precise protein quantification to provide a view of protein expression, function, and structure across various sample types.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.